| 000 | 01633 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514195020.0 | ||
| 264 | 0 | _c20040812 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a1460-2105 | ||
| 024 | 7 |
_a10.1093/jnci/djh232 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCastle, Philip E | |
| 245 | 0 | 0 |
_aRe: Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cAug 2004 |
||
| 300 |
_a1181-2; author reply 1182-3 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xvirology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCervix Uteri _xvirology |
| 650 | 0 | 4 |
_aDNA, Viral _xisolation & purification |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMouth _xvirology |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aOropharyngeal Neoplasms _xvirology |
| 650 | 0 | 4 |
_aPapillomaviridae _xgenetics |
| 650 | 0 | 4 |
_aPapillomavirus Infections _xcomplications |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTonsillar Neoplasms _xvirology |
| 650 | 0 | 4 |
_aTumor Virus Infections _xcomplications |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _xvirology |
| 650 | 0 | 4 |
_aViral Vaccines _xtherapeutic use |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 96 _gno. 15 _gp. 1181-2; author reply 1182-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/djh232 _zAvailable from publisher's website |
| 999 |
_c14992935 _d14992935 |
||